BROS vs VRTX · P/E 105, rev $1.02B vs P/E 30, rev $3.33B
Dutch Bros Inc (BROS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BROS and VRTX stock pages for the full models.
Not investment advice.